% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rosemariecorbin rosemariecorbin Mar 20, 2012 3:40 PM Flag

    Clinical Trial Update

    My point that this company in the best of scenarios is years from revenues regardless of how you screw up links

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I see that went totally over your head. I was responding to your other ID reg_dossier that approval is not contingent on the completion of the extension study as you (he, it) tried to insinuate. It is hinged on results of the European CF pIII, which I purposefully linked and which is slated for completion in August 2013 and if results are as anywhere near as good as pII, we should expect regulatory approval with a revenue stream likely within 2 years, not 4 years. That of course excludes any licensing revenue from Iplex or cisplatin that could be announced before Arikace approval.

19.44+1.04(+5.65%)Oct 2 4:00 PMEDT